These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6795746)

  • 21. Hemophilia and von Willebrand's disease: genetic considerations.
    Green D
    Ann Clin Lab Sci; 1980; 10(2):123-7. PubMed ID: 6770741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on the Factor VIII/von Willebrand factor antigen on human platelets.
    Coller BS; Hirschman RJ; Gralnick HR
    Thromb Res; 1975 Jun; 6(6):469-80. PubMed ID: 1098217
    [No Abstract]   [Full Text] [Related]  

  • 23. Crossed immunoelectrophoretic pre-peak of canine factor VIII-related antigen.
    Bass AI; Benson RE; Dodds WJ
    Thromb Res; 1980 Nov; 20(3):343-6. PubMed ID: 6782699
    [No Abstract]   [Full Text] [Related]  

  • 24. Absence of blocking antibody in non-inhibitor haemophilic plasma.
    Pool J; Kaelin AC
    Thromb Haemost; 1977 Oct; 38(3):717-20. PubMed ID: 304261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoclonal antibodies to human procoagulant factor VIII.
    Rotblat F; Goodall AH; O'Brien DP; Rawlings E; Middleton S; Tuddenham EG
    J Lab Clin Med; 1983 May; 101(5):736-46. PubMed ID: 6403638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heterogeneity of human procoagulant factor VIII (VIIIC) antibodies in their reaction with factor VIII related antigen (VIIIRAG).
    Furlong RA; Peake IR
    Thromb Res; 1984 Jun; 34(5):379-87. PubMed ID: 6204399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of the von Willebrand's disease antigen (factor VIII-related antigen) in plasma by quantitative immunoelectrophoresis.
    Zimmerman TS; Hoyer LW; Dickson L; Edgington TS
    J Lab Clin Med; 1975 Jul; 86(1):152-9. PubMed ID: 1080496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kinetics of the inhibitor of factor VIII:C in patients with hemophilia A. A study of the cooperative group of hemophilia.
    Ambriz-Fernández R; Reyna-Fregoso MP; Pizzuto-Chávez J; Rodríguez-Moyado H; Farfán-Canto JM; Trueba-Christy E; Collazo-Jaloma J
    Arch Invest Med (Mex); 1985; 16(3):225-35. PubMed ID: 3938639
    [No Abstract]   [Full Text] [Related]  

  • 29. [Development of a competitive enzyme immunoassay for factor VIII-related antigen].
    Riemer J; Kopperschläger G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(1):72-83. PubMed ID: 6202602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hemophilia A: early detection of women carriers by Laurell's quantitative immunoelectrophoresis].
    Biland L; Nyman D; Benz A; Duckert F
    Schweiz Med Wochenschr; 1975 May; 105(19):620-2. PubMed ID: 1080293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factor VIII-related antigen pre-peak on crossed immunoelectrophoresis: a non-random phenomenon.
    Miller CH; Hilgartner MW; LeStrange RC; McLaughlin GW
    Thromb Res; 1982 Jan 1-15; 25(1-2):101-7. PubMed ID: 6801807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gel filtration patterns of factor VIII coagulant antigen and factor VIII related antigen in normal and von Willebrand's disease.
    Chediak J; Peake I; Bloom A
    Thromb Haemost; 1983 Aug; 50(2):509-12. PubMed ID: 6415844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
    CMAJ; 1995 Jul; 153(2):147-57. PubMed ID: 7600466
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nasal spray desmopressin (DDAVP) for mild hemophilia A and von Willebrand disease.
    Rose EH; Aledort LM
    Ann Intern Med; 1991 Apr; 114(7):563-8. PubMed ID: 1900403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acquired von Willebrand's disease. Evidence for a quantitative and qualitative factor VIII disorder.
    Joist JH; Cowan JF; Zimmerman TS
    N Engl J Med; 1978 May; 298(18):988-91. PubMed ID: 306064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Structure and function of clotting factor VIII: the results of fundamental research].
    Beck EA; Furlan M
    Ther Umsch; 1979 Apr; 36(4):294-300. PubMed ID: 377554
    [No Abstract]   [Full Text] [Related]  

  • 37. Characteristics of various factor VIII concentrates used in treatment of haemophilia A.
    Nilsson IM; Hedner U
    Br J Haematol; 1977 Dec; 37(4):543-57. PubMed ID: 304740
    [No Abstract]   [Full Text] [Related]  

  • 38. The interaction between factor VIII clotting antigen and phospholipids in genetic variants of hemophilia and von Willebrand's disease.
    Kobayashi I; Lamme S; Nilsson IM
    Thromb Res; 1984 Jul; 35(1):65-75. PubMed ID: 6433504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune tolerance induction with highly purified plasma-derived factor VIII containing von Willebrand factor in hemophilia A patients with high-responding inhibitors.
    Orsini F; Rotschild C; Beurrier P; Faradji A; Goudemand J; Polack B
    Haematologica; 2005 Sep; 90(9):1288-90. PubMed ID: 16154861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunoradiometric measurement of the factor VIII procoagulant antigen.
    Lazarchick J; Hoyer LW
    J Clin Invest; 1978 Nov; 62(5):1048-52. PubMed ID: 81838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.